- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nonsquamous Nonsmall Cell Neoplasm of Lung in Australia
Total 639 results
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
Arbeitsgemeinschaft medikamentoese TumortherapieSanofi; Roche Pharma AGCompleted
-
Maia BiotechnologyRecruitingCarcinoma, Non-Small-Cell LungPoland, Australia, Bulgaria, Hungary
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Small Cell Lung Cancer | Prostate Cancer | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamousUnited States, Korea, Republic of, Italy, United Kingdom, Australia, Taiwan
-
Mologen AGCompletedSmall Cell Lung CancerBelgium, Spain, Austria, Germany
-
CureVacTerminatedNon-Small Cell Lung CarcinomaGermany, Switzerland, Austria
-
Peter MacCallum Cancer Centre, AustraliaCompleted
-
MorphotekCompletedAdenocarcinoma of the LungSpain, United States, Australia, Canada, Germany, Italy, Poland, Russian Federation
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
Genentech, Inc.CompletedHead and Neck CancerUnited States, Germany, Spain, France, Australia, Hungary, Belgium, Bulgaria, United Kingdom, Italy, Romania
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
AmgenRecruitingSmall Cell Lung Cancer | Limited Stage Small Cell Lung CancerJapan, Taiwan, Australia, China, United States, Turkey, Korea, Republic of
-
Eli Lilly and CompanyTerminatedMelanoma | Neoplasms | Carcinoma, Non-Small-Cell Lung | Neoplasm Metastasis | Colorectal NeoplasmsUnited States, Spain, Australia, France
-
European Organisation for Research and Treatment...CompletedLung CancerFrance, Spain, Denmark, Italy, Austria, Germany
-
Hoffmann-La RocheActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Germ Cell and Embryonal | Head and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung | Bronchial Diseases | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Neoplasms, Nerve... and other conditionsItaly, Korea, Republic of, Australia, Spain, Argentina, Belgium, Brazil, France, Portugal, United Kingdom, United States, Japan, Mexico, Poland, Norway, Costa Rica, Switzerland, Netherlands, Germany, Sweden, Turkey, Ireland, Panama
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
NCIC Clinical Trials GroupCompletedLung CancerCanada, Singapore, Australia, Romania, Argentina, Brazil
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Health Service, United...Active, not recruitingBreast Cancer | Carcinoma, Non-Small-Cell Lung | Prostate CancerUnited Kingdom, Australia
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
Medical University InnsbruckTerminatedColorectal Cancer | Non-small Cell Lung Cancer | Renal Cell Cancer | Hepatocellular CancerAustria
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
Head and Neck Cancer International GroupCompletedHead and Neck Squamous Cell Carcinoma | Extranodal Extension | Human Papilloma Virus Related CarcinomaSwitzerland, United Kingdom, United States, Germany, Australia, France, Spain, Denmark
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedCarcinoma, Non-small-cell LungCanada, United States, Australia, Singapore, Israel, China, Argentina, Germany, Sweden, Brazil, Chile, Greece, Mexico, New Zealand, Romania, South Africa, Thailand
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerChina, Italy, Australia, Poland, Netherlands, India, Austria, Spain, Bulgaria, United States, Greece, Turkey, Brazil, Croatia, Czech Republic, Germany, Hungary, Korea, Republic of, Romania, Taiwan
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CarcinomaPoland, Russian Federation, United States, Australia, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, France, Romania
-
Eucure (Beijing) Biopharma Co., LtdWithdrawnHCC | NSCLC Stage IV | NSCLC Stage IIIBChina, Australia, Taiwan, Armenia, Austria
-
Arcus Biosciences, Inc.Gilead SciencesRecruitingAdvanced Non-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, United Kingdom, Taiwan, Spain
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Endometrial Neoplasms | Carcinoma, Squamous Cell of Head and NeckUnited States, Australia, Canada
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Arbeitsgemeinschaft medikamentoese TumortherapieHoffmann-La Roche; LipomedCompletedLymphoma of Mucosa-Associated Lymphoid TissueAustria
-
Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Carcinoma (HNSCC)United States, Australia, Austria, Brazil, France, Israel, Korea, Republic of, Norway, Spain, United Kingdom
-
AmMax Bio, Inc.RecruitingTenosynovial Giant Cell Tumor | Pigmented Villonodular Synovitis | TGCTNetherlands, Australia, United States
-
Hoffmann-La RocheRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Canada, Turkey, Brazil, Spain, France, Germany, Australia, Italy, Belgium, Mexico
-
Regeneron PharmaceuticalsSuspendedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
Impact Therapeutics, Inc.RecruitingSmall Cell Lung Cancer | Advanced Solid TumoursTaiwan, Korea, Republic of, China, Australia, United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States, Australia, Peru, Puerto Rico
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
AmgenRecruitingSmall Cell Lung CarcinomaUnited States, Spain, Austria, Switzerland, United Kingdom, France, Australia, Germany, Japan, Taiwan, Poland, Hong Kong, Netherlands